Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze VRAX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate VRAX investment potential.

What is VRAX stock price today?

Get real-time VRAX stock price, historical data, and price charts on Financhill. Track VRAX performance with our advanced analysis tools.

Is VRAX a good investment?

Evaluate VRAX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy VRAX stock?

To buy VRAX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of VRAX?

View detailed market capitalization data and company valuation metrics for VRAX on our comprehensive analysis page.

What is the P/E ratio of VRAX?

Use our fundamental analysis tools to view VRAX P/E ratio and compare valuation metrics with industry peers.

What are VRAX earnings?

View VRAX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Virax Biolabs Group Ltd. 10K Form

Sell

VRAX
Virax Biolabs Group Ltd.

Last Price:

$0.39

Seasonality Move:

-34.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VRAX News And Ratings

See the #1 stock for the next 7 days that we like better than VRAX

VRAX Financial Statistics

Sales & Book Value

Annual Sales:	$6.3K
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$1.99
Price / Book:	0.6

Profitability

EPS (TTM):	-1.25210
Net Income (TTM):	$-5.7M
Gross Margin:	$-396.5K
Return on Equity:	-100.4%
Return on Assets:	-89.93%

Virax Biolabs Group Ltd. Earnings Forecast

Key Virax Biolabs Group Ltd. Financial Ratios

The Gross Profit Margin over the past 6 years for VRAX is -6,293.65%.
The Selling, General & Administrative Expenses for VRAX have been equal to 68,730.16% of Gross Profit Margin.
The Research & Development expenses have been 28,250.79% of Revenue.
The Net Earning history of VRAX is -96,304.76% of Total Revenues.
Per Share Earnings over the last 6 years have been positive in 3 years.

Virax Biolabs Group Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Health Care Providers & Services
Sector:	Health Care
Current Symbol:	VRAX
Website:	viraxbiolabs.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	11.58
Quick Ratio:	10.54

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

VRAX Technical Analysis vs Fundamental Analysis